MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647066455 A) filed by Aurigene Oncology Limited on May 27, 2026, for Amino-Substituted Pyridazine Compounds As Smarca2 And/Or Smarca4 Degraders.
Inventors include Abbineni, Chandrasekhar; Samajdar, Susanta; and Kuila, Bilash.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present disclosure provides amino-substituted pyridazine compounds of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of disease or disorder dependent upon SMARCA2 and/or SMARCA4 in a subject. The present disclosure also provides pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
Disclaimer: Curated by HT Syndication.
